Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premarin in Androgen-Independent Prostate Cancer
NCT00134654Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Mar 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of conjugated estrogens in prostate cancer (PCa), sponsored by Dana-Farber Cancer Institute. Started Mar 2003; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00134654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134654.